RAC 5.88% $1.89 race oncology ltd

Ann: December 2023 Preclinical & Clinical Program Update, page-22

  1. 595 Posts.
    lightbulb Created with Sketch. 242
    Hi Daniel,

    Whilst you are answering questions, this is bit of a simple one I guess. If you don't mind.
    My father has AML and is in his 80's, he is currently taking Venetoclax (Abbvie) orally and AraC injections. It is working very, very well.

    My question is this: Down the track, how would a Bis + Decitabine combo fit into AML treatment? Is this something that would only be prescribed to patients who have failed previous lines of therapy? Or could it be a front line thing?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.89
Change
0.105(5.88%)
Mkt cap ! $325.2M
Open High Low Value Volume
$1.84 $1.95 $1.82 $943.3K 504.3K

Buyers (Bids)

No. Vol. Price($)
1 350 $1.89
 

Sellers (Offers)

Price($) Vol. No.
$1.92 8006 2
View Market Depth
Last trade - 14.24pm 11/06/2024 (20 minute delay) ?
Last
$1.88
  Change
0.105 ( 8.80 %)
Open High Low Volume
$1.85 $1.94 $1.82 49954
Last updated 15.06pm 11/06/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.